Life sciences CI teams are navigating an explosion of data, from clinical trials and regulatory updates to patents, publications, and market activity. The challenge is no longer finding information; it is turning fragmented signals into timely, decision-ready intelligence the whole business can trust.
This session explores how AI-driven competitive intelligence is changing that. As general AI puts fast answers in everyone's hands, the differentiator for CI is no longer speed alone but trust: intelligence you can act on because you can prove where it came from. We will look at how conversational, AI-driven approaches let teams ask questions in plain language and get sourced, decision-ready answers, and how that democratizes intelligence across R&D, commercial, and executive stakeholders without sacrificing rigor or governance.
Attendees will leave with a practical model for evolving their function from reactive reporting to proactive strategic partnership, and a framework for evaluating AI-driven CI in an era where the source of an answer matters as much as the answer itself.
Key takeaways
- How to turn fragmented signals into decision-ready intelligence teams can act on and defend
- Why trust, source traceability, and governance are becoming the real differentiators for AI-driven CI
- How conversational, self-serve intelligence democratizes CI across the organization
- A maturity model for moving from reactive reporting to proactive strategic partnership
